摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-((S)-5-hydroxymethyl-2-oxo-oxazolidin-3-yl)-4H-benzo[1,4]thiazin-3-one | 1072794-28-5

中文名称
——
中文别名
——
英文名称
6-((S)-5-hydroxymethyl-2-oxo-oxazolidin-3-yl)-4H-benzo[1,4]thiazin-3-one
英文别名
(5S)-5-(hydroxymethyl)-3-(3-oxo-4H-1,4-benzothiazin-6-yl)-1,3-oxazolidin-2-one
6-((S)-5-hydroxymethyl-2-oxo-oxazolidin-3-yl)-4H-benzo[1,4]thiazin-3-one化学式
CAS
1072794-28-5
化学式
C12H12N2O4S
mdl
——
分子量
280.304
InChiKey
LFKDPFMLMSQKOH-QMMMGPOBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    104
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] OXAZOLIDINONE DERIVATIVES<br/>[FR] DÉRIVÉS D'OXAZOLIDINONE
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:WO2009104159A1
    公开(公告)日:2009-08-27
    The invention relates to compounds of Formula (I) wherein U, V, W, R1, R1b, A and G are as defined in the description, to pharmaceutically acceptable salts of such compounds and to the use of these compounds in the manufacture of a medicament for the prevention or treatment of a bacterial infection.
    这项发明涉及到式(I)中U、V、W、R1、R1b、A和G的化合物,这些化合物的药学上可接受的盐,以及这些化合物在制备用于预防或治疗细菌感染的药物方面的用途。
  • OXAZOLIDINONE ANTIBIOTIC DERIVATIVES
    申请人:Gude Markus
    公开号:US20100137290A1
    公开(公告)日:2010-06-03
    The invention relates to antibacterial compounds of formula I wherein R 1 is hydrogen, halogen, hydroxy, alkoxy or cyano; Y 1 and Y 2 each represent CH, one or two of U, V, W and X represent(s) N and the remaining each represent CH or, in the case of X, may also represent CR a , R a being halogen, and, in the case of W, may also represent CR b , or each of U, V, W, X, Y 1 and Y 2 represents CH, or each of U, V, W, X and Y 1 represents CH and Y 2 represents N, or also one or, provided R 1 is hydrogen, two of U, V, W, X, Y 1 and Y 2 represent(s) CRC and the remaining each represent CH, R b being alkoxy, alkoxycarbonyl or alkoxyalkoxy and R c being, each time it occurs, independently represents hydroxy or alkoxy; A-B-D represents a chain of 4 to 6 atoms, which 4 to 6 atoms are seleted from carbon, oxygen and nitrogen and may be substituted; E is one of the following groups: in which Z is CH or N and Q is O or S, or E is a phenyl group which is substituted once or twice in the meta and/or para position(s); and to salts of such compounds.
    本发明涉及式I的抗菌化合物,其中R1为氢、卤素、羟基、烷氧基或氰基;Y1和Y2各自代表CH,一个或两个U、V、W和X代表N,其余各自代表CH,或者在X的情况下,也可以代表CRa,其中Ra为卤素,并且在W的情况下,也可以代表CRb,或者U、V、W、X、Y1和Y2各自代表CH,或者U、V、W、X和Y1各自代表CH,而Y2代表N,或者,如果R1为氢,则一个或两个U、V、W、X、Y1和Y2代表CRC,其余各自代表CH,其中Rb为烷氧基、烷氧羰基或烷氧基烷氧基,Rc每次出现时独立地代表羟基或烷氧基;A-B-D代表4至6个原子的链,这4至6个原子选自碳、氧和氮,并且可以被取代;E是以下组之一:其中Z为CH或N,Q为O或S,或者E为苯基,该苯基在间位和/或对位被取代一次或两次;以及这类化合物的盐。
  • AZATRICYCLIC ANTIBIOTIC COMPOUNDS
    申请人:Hubschwerlen Christian
    公开号:US20100331318A1
    公开(公告)日:2010-12-30
    The invention relates to antibacterial compounds of formula I wherein n is 0 or 1; R 1 represents H or F; U represents CH 2 or, provided n is 1, O or NH; “-----” is a bond or is absent; V represents CH or N when “-----” is a bond, or CH 2 or NH when “-----” is absent; W represents CH or N; A represents —(CH—) p —NH—(CH 2 ) q — wherein p is 1 and q is 1 or 2 or, provided U represents CH 2 and n is 1, p may also be 0 and q is then 2; G represents one of the groups wherein Z represents N or CH and Q represents O or S; and Z 0 , Z 1 and Z 2 each represent CH, or Z 0 and Z 1 each represent CH and Z 2 represents N, or Z 0 represents CH, Z 1 represents N and Z 2 represents CH or N, or Z 0 represents N and Z 1 and Z 2 each represent CH; and to salts of such compounds.
    该发明涉及具有以下结构的抗菌化合物,其中n为0或1;R1代表H或F;U代表CH2或,如果n为1,则为O或NH;“-----”是一个键或不存在;V代表CH或N,当“-----”是一个键时,或CH2或NH,当“-----”不存在时;W代表CH或N;A代表—(CH—)p—NH—(CH2)q—,其中p为1,q为1或2,或者,如果U代表CH2且n为1,则p也可以为0,q则为2;G代表以下组之一,其中Z代表N或CH,Q代表O或S;Z0、Z1和Z2分别代表CH,或Z0和Z1分别代表CH且Z2代表N,或Z0代表CH,Z1代表N且Z2代表CH或N,或Z0代表N且Z1和Z2分别代表CH;以及这些化合物的盐。
  • OXAZOLIDINONE DERIVATIVES
    申请人:Hubschwerlen Christian
    公开号:US20100331308A1
    公开(公告)日:2010-12-30
    The invention relates to compounds of Formula (I) wherein U, V, W, R 1 , R 1b , A and G are as defined in the description, to pharmaceutically acceptable salts of such compounds and to the use of these compounds in the manufacture of a medicament for the prevention or treatment of a bacterial infection.
    本发明涉及化合物(I)的公式,其中U,V,W,R1,R1b,A和G如描述中所定义,以及这些化合物的药学上可接受的盐,以及使用这些化合物制造预防或治疗细菌感染的药物。
  • 5-AMINOCYCLYLMETHYL-OXAZOLIDIN-2-ONE DERIVATIVES
    申请人:Hubschwerlen Christian
    公开号:US20110003789A1
    公开(公告)日:2011-01-06
    The invention relates to antibacterial compounds of formula I wherein one or two of U, V, W, and X represent N, the rest represent CH or, in the case of X, may also represent CR a wherein R a is fluorine; R 1 represents alkoxy, halogen or cyano; R 2 represents H, CH 2 OH, CH 2 N 3 , CH 2 NH 2 , alkylcarbonylaminomethyl or triazol-1-ylmethyl; R 3 represents H, or, when n is 1, R 3 may also represent OH, NH 2 , NHCOR 6 or triazol-1-yl; A represents CR 4 ; K represents O, NH, OCH 2 , NHCO, NHCH 2 , CH 2 NH, CH 2 CH 2 , CH═CH, CHOHCHOH or CHR 5 ; R 4 represents H or together with R 5 forms a bond, or also R 4 can represent OH when K is not O, NH, OCH 2 or NHCO; R 5 represents OH or together with R 4 forms a bond; R 6 represents alkyl; m is 0 or 1 and n is 0 or 1; and G is as defined in the description; and to salts of such compounds.
    本发明涉及式I的抗菌化合物,其中U、V、W和X中的一个或两个代表N,其余代表CH,或在X的情况下,也可以代表CRa,其中Ra是氟;R1代表烷氧基、卤素或氰基;R2代表H、CH2OH、CH2N3、CH2NH2、烷基羰基氨甲基或三唑-1-基甲基;R3代表H,或当n为1时,R3也可以代表OH、NH2、NHCOR6或三唑-1-基;A代表CR4;K代表O、NH、OCH2、NHCO、NHCH2、CH2NH、CH2CH2、CH═CH、CHOHCHOH或CHR5;R4代表H或与R5形成键,或当K不是O、NH、OCH2或NHCO时,R4也可以代表OH;R5代表OH或与R4形成键;R6代表烷基;m为0或1,n为0或1;G如描述中所定义;以及这些化合物的盐。
查看更多